Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents

Clinical trial NCT04710628 · COMPLETED

Trial details

NCT number: NCT04710628
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Thymic Carcinoma Thymoma Type B3

Start date: 2021-09-21
Primary completion: 2024-07-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.